125 related articles for article (PubMed ID: 27424890)
21. Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation.
Ven HV; Vandervoort J; Weyenberg W; Apers S; Ludwig A
J Microencapsul; 2012; 29(2):115-25. PubMed ID: 22047548
[TBL] [Abstract][Full Text] [Related]
22. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
23. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
[TBL] [Abstract][Full Text] [Related]
24. The binary complex of poly(PEGMA-co-MAA) hydrogel and PLGA nanoparticles as a novel oral drug delivery system for ibuprofen delivery.
Shang Q; Huang S; Zhang A; Feng J; Yang S
J Biomater Sci Polym Ed; 2017 Nov; 28(16):1874-1887. PubMed ID: 28693380
[TBL] [Abstract][Full Text] [Related]
25. Chitosan-Coated PLGA Nanoparticles Loaded with
Azzazy HME; Fahmy SA; Mahdy NK; Meselhy MR; Bakowsky U
Nanomaterials (Basel); 2021 Sep; 11(9):. PubMed ID: 34578755
[TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG)-loaded poly(lactic acid-co-glycolic acid) nanoparticles.
Pradhan R; Poudel BK; Choi JY; Choi IS; Shin BS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2015; 38(5):734-41. PubMed ID: 24824337
[TBL] [Abstract][Full Text] [Related]
27. Injectable PLGA/Hydroxyapatite/Chitosan Microcapsules Produced by Supercritical Emulsion Extraction Technology: An In Vitro Study on Teriparatide/Gentamicin Controlled Release.
Della Porta G; Campardelli R; Cricchio V; Oliva F; Maffulli N; Reverchon E
J Pharm Sci; 2016 Jul; 105(7):2164-72. PubMed ID: 27290629
[TBL] [Abstract][Full Text] [Related]
28. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
[TBL] [Abstract][Full Text] [Related]
29. Novel PLGA-based nanoparticles for the oral delivery of insulin.
Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
[TBL] [Abstract][Full Text] [Related]
30. PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery.
Raza A; Miles JA; Sime FB; Ross BP; Roberts JA; Popat A; Kumeria T; Falconer JR
Int J Pharm; 2021 Mar; 597():120280. PubMed ID: 33540004
[TBL] [Abstract][Full Text] [Related]
31. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
[TBL] [Abstract][Full Text] [Related]
32. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
[TBL] [Abstract][Full Text] [Related]
33. Single-Dose Electrospun Nanoparticles-in-Nanofibers Wound Dressings with Enhanced Epithelialization, Collagen Deposition, and Granulation Properties.
Ali IH; Khalil IA; El-Sherbiny IM
ACS Appl Mater Interfaces; 2016 Jun; 8(23):14453-69. PubMed ID: 27215336
[TBL] [Abstract][Full Text] [Related]
34. The comparative study of influence of lactic and glycolic acids copolymers type on properties of daunorubicin loaded nanoparticles and drug release.
Nikolskaya E; Sokol M; Faustova M; Zhunina O; Mollaev M; Yabbarov N; Tereshchenko O; Popov R; Severin E
Acta Bioeng Biomech; 2018; 20(1):65-77. PubMed ID: 29658530
[TBL] [Abstract][Full Text] [Related]
35. Depot injectable biodegradable nanoparticles loaded with recombinant human bone morphogenetic protein-2: preparation, characterization, and in vivo evaluation.
Hassan AH; Hosny KM; Murshid ZA; Alhadlaq A; Alyamani A; Naguib G
Drug Des Devel Ther; 2015; 9():3599-606. PubMed ID: 26203226
[TBL] [Abstract][Full Text] [Related]
36. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
Bairwa K; Jachak SM
J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
[TBL] [Abstract][Full Text] [Related]
37. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Mistry NP; Desai JL; Thakkar HP
J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
[TBL] [Abstract][Full Text] [Related]
38. Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization.
Sah AK; Suresh PK
Curr Drug Deliv; 2017; 14(5):676-689. PubMed ID: 27480117
[TBL] [Abstract][Full Text] [Related]
39. Uptake mechanism of furosemide-loaded pegylated nanoparticles by cochlear cell lines.
Youm I; Youan BB
Hear Res; 2013 Oct; 304():7-19. PubMed ID: 23747541
[TBL] [Abstract][Full Text] [Related]
40. Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release.
Encinas-Basurto D; Konhilas JP; Polt R; Hay M; Mansour HM
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]